Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • AIDS / HIV / Sexuell übertragbare Krankheiten
  • Allergien
  • Alternative Medizin
  • Alzheimer
  • Arthritis (Reuma) / Osteoporose
  • Atemwegserkrankungen / Asthma
  • Biopharmazeutika
  • Frauenkrankheiten (Gynäkologie)
  • Generika
  • Hauterkrankungen (Dermatologie)
  • Hepatitis
  • Herz-Kreislauf-Erkrankungen (Kardiologie)
  • Hormone / Stoffwechsel
  • Infektionskrankheiten
  • Krebs
  • Magen-Darm (Gastroenterologie)
  • Männerkrankheiten (Andrologie) / Urologie
  • Marketing / Zielgruppen
  • OTC-Medikamente
  • Psychische Erkrankungen (Neurologie)
  • Schmerzen / Migräne / Analgetika
  • Supplements / Ergänzungsstoffe
  • weitere Studien Pharmaindustrie / Medikamente
  • Zuckererkrankungen (Diabetes) / Fettleibigkeit
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bosnien-Herzegowina
  • Bulgarien
  • Dänemark
  • Deutschland
  • Estland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Island
  • Italien
  • Kroatien
  • Lettland
  • Litauen
  • Luxemburg
  • Malta
  • Mazedonien
  • Moldawien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Serbien
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Weißrussland
  • Weißrussland
  • Zypern
  • Asien / Pazifik
  • Bangladesch
  • China
  • Hong Kong
  • Indien
  • Indonesien
  • Japan
  • Kasachstan
  • Malaysia
  • Neuseeland
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Ghana
  • Iran
  • Israel
  • Kamerun
  • Katar
  • Kenia
  • Marokko
  • Nigeria
  • Oman
  • Saudi Arabien
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Peru
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • AIK - Kohlhaas & Partner
  • Biopharm Reports
  • Business Insights
  • Canadean
  • cbc market intelligence
  • Datamonitor
  • Euromonitor
  • GBI Research
  • Global Markets Direct
  • Global Research & Data Services
  • GlobalData
  • ICD Research
  • Koncept Analytics
  • Life Science Analytics
  • MarketLine
  • MarketsandMarkets
  • Ovum
  • Pesquisa GmbH
  • Technavio
  • Verdict
  • Zukunftsinstitut
  • Filter zurücksetzen
Sprache
  • Deutsch
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • Filter zurücksetzen
laedt

Marktanalyse - Aplastic Anemia Global Clinical Trials Review, H2, 2012

GlobalData

GlobalData

7 / 2012
77 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

1.933,49 €*
( 2.500,00 $)
PDF-Datei per E-Mail, Single User Price , versandkostenfrei
3.866,98 €*
( 5.000,00 $)
PDF-Datei per E-Mail, Site License Price** , versandkostenfrei
5.800,46 €*
( 7.500,00 $)
PDF-Datei per E-Mail, Enterprisewide Price (Global Site License)*** , versandkostenfrei


Aplastic Anemia Global Clinical Trials Review, H2, 2012


Summary


GlobalData's clinical trial report, 'Aplastic Anemia Global Clinical Trials Review, H2, 2012' provides data on the Aplastic Anemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aplastic Anemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aplastic Anemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)


Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Aplastic Anemia 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by BRIC Nations 14

Clinical Trials by G7 Nations 15

Clinical Trials in G7 Nations by Trial Status 16

Clinical Trials by E7 Nations 17

Clinical Trials in E7 Nations by Trial Status 18

Clinical Trials by Phase 19

In Progress Trials by Phase 20

Clinical Trials by Trial Status 21

Unaccomplished Trials of Aplastic Anemia 22

Subjects Recruited Over a Period of Time 25

Prominent Sponsors 26

Top Companies Participating in Aplastic Anemia Therapeutics Clinical Trials 28

Prominent Drug Comparison 29

Clinical Trial Profiles 30

Clinical Trial Overview of Top Companies 30

Shenzhen Zhongxing Yangfan Biotech Co. Ltd. 30

Clinical Trial Overview of Shenzhen Zhongxing Yangfan Biotech Co. Ltd. 30

Bharat Serums And Vaccines Limited 31

Clinical Trial Overview of Bharat Serums And Vaccines Limited 31

Novartis AG 32

Clinical Trial Overview of Novartis AG 32

Clinical Trial Overview of Top Universities / Institutes / Hospitals 33

The University of Texas M. D. Anderson Cancer Center 33

Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 33

Case Comprehensive Cancer Center 34

Clinical Trial Overview of Case Comprehensive Cancer Center 34

Baylor College of Medicine 35

Clinical Trial Overview of Baylor College of Medicine 35

Fred Hutchinson Cancer Research Center 36

Clinical Trial Overview of Fred Hutchinson Cancer Research Center 36

King Faisal Specialist Hospital & Research Center 37

Clinical Trial Overview of King Faisal Specialist Hospital & Research Center 37

Istituto Giannina Gaslini 38

Clinical Trial Overview of Istituto Giannina Gaslini 38

Erasmus MC 39

Clinical Trial Overview of Erasmus MC 39

Memorial Sloan Kettering Cancer Center 40

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 40

The Cleveland Clinic 41

Clinical Trial Overview of The Cleveland Clinic 41

Asan Medical Center 42

Clinical Trial Overview of Asan Medical Center 42

Seoul National University Hospital 43

Clinical Trial Overview of Seoul National University Hospital 43

Tufts Medical Center 44

Clinical Trial Overview of Tufts Medical Center 44

Thomas Jefferson University 45

Clinical Trial Overview of Thomas Jefferson University 45

Sidney Kimmel Comprehensive Cancer Center 46

Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 46

University Hospital Freiburg 47

Clinical Trial Overview of University Hospital Freiburg 47

Emory University 48

Clinical Trial Overview of Emory University 48

Beth Israel Deaconess Medical Center 49

Clinical Trial Overview of Beth Israel Deaconess Medical Center 49

University of Minnesota 50

Clinical Trial Overview of University of Minnesota 50

Massachusetts General Hospital 51

Clinical Trial Overview of Massachusetts General Hospital 51

Duke University 52

Clinical Trial Overview of Duke University 52

Five Key Clinical Profiles 53

Appendix 74

Abbreviations 74

Definitions 74

Research Methodology 75

Secondary Research 75

About GlobalData 76

Contact Us 76

Disclaimer 76

Source 77





List of Tables

Aplastic Anemia Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7

Aplastic Anemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8

Aplastic Anemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9

Aplastic Anemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 10

Aplastic Anemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11

Aplastic Anemia Therapeutics Clinical Trials, North America, Top Countries, 2012* 12

Aplastic Anemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13

Aplastic Anemia Therapeutics Clinical Trials, BRIC Countries, 2012* 14

Aplastic Anemia Therapeutics Clinical Trials, G7 Countries, 2012* 15

Aplastic Anemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16

Aplastic Anemia Therapeutics Clinical Trials, E7 Countries, 2012* 17

Aplastic Anemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18

Aplastic Anemia Therapeutics Market, Global, Clinical Trials by Phase, 2012* 19

Aplastic Anemia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 20

Aplastic Anemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21

Aplastic Anemia Therapeutics Market, Global, Suspended Clinical Trials, 2012* 22

Aplastic Anemia Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 23

Aplastic Anemia Therapeutics Market, Global, Terminated Clinical Trials, 2012* 24

Aplastic Anemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 25

Aplastic Anemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27

Aplastic Anemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28

Aplastic Anemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shenzhen Zhongxing Yangfan Biotech Co. Ltd., 2012* 30

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bharat Serums And Vaccines Limited, 2012* 31

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 32

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 33

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 34

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2012* 35

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 36

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by King Faisal Specialist Hospital & Research Center, 2012* 37

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Giannina Gaslini, 2012* 38

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2012* 39

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 40

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2012* 41

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2012* 42

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 43

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts Medical Center, 2012* 44

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2012* 45

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012* 46

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2012* 47

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012* 48

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 49

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2012* 50

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 51

Aplastic Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 52





List of Figures

Aplastic Anemia Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7

Aplastic Anemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8

Aplastic Anemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9

Aplastic Anemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 10

Aplastic Anemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11

Aplastic Anemia Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12

Aplastic Anemia Therapeutics Clinical Trials, BRIC Countries (%), 2012* 14

Aplastic Anemia Therapeutics Clinical Trials, G7 Countries (%), 2012* 15

Aplastic Anemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16

Aplastic Anemia Therapeutics Clinical Trials, E7 Countries (%), 2012* 17

Aplastic Anemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18

Aplastic Anemia Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 19

Aplastic Anemia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 20

Aplastic Anemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21

Aplastic Anemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 25

Aplastic Anemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 26

Aplastic Anemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28

Aplastic Anemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29

GlobalData Methodology 75

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Hinweise: **The report can be shared by users within one office (one geographical location) ***Across Geographical locations (by the purchasing company only)

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: